Brief: Skye Bioscience Says Kaitlyn Arsenault To Step Down As CFO Effective Feb 20
20/02/2026 22:35
Feb 20 (Reuters) - Skye Bioscience Inc SKYE.O: SKYE BIOSCIENCE INC - KAITLYN ARSENAULT TO STEP DOWN AS CFO EFFECTIVE FEB 20, 2026 - SEC FILING Source text: [ID:n0001628280-26-010186] Further company coverage: SKYE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Skye Bioscience
See all newsRCS - Redx Pharma Limited - Redx to Present Poster on RXC008 at UEG Week
RCS - Redx Pharma Limited - Redx Announces ROCKETEER Phase 2 Trial for RXC008
Brief: Skye Bioscience Says John Sharp Resigns As CFO - SEC Filing
Brief: Skye Bioscience - Enters $22 Million Securities Purchase Agreement With Redmile Biopharma Investments Iii - SEC Filing
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM